Clinical Trial Update: Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH) [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating omega-3 fish oil supplements versus placebo in patients with nonalcoholic steatohepatitis and nonalcoholic fatty…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Omega-3 fish oil supplement (Omega-3 fatty acids)

Snippet

Sponsor: University of Virginia | Conditions: Non-alcoholic Steatohepatitis, Fatty Liver | Phase 2, Phase 3 | Status: COMPLETED